News Posts List
Reducing Risk Of Recurrence And A Stabilization In Incidence Of Renal Cell Carcinoma Will Limit Growth Of Drug-Treatment Opportunities
11/25/2010
Projected improvements in recurrence-free survival and a discontinuation of the historically observed increases in the incidence rate of renal cell carcinoma (RCC) will limit growth of new drug-treatment opportunities for advanced disease in RCC.
Cancer nutrition rehabilitation program (PDF)
11/25/2010
The Cancer Nutrition Rehabilitation (cnr) program at the McGill University Health Centre is an interdisciplinary 8-week treatment program offering patients information, education, treatment, and support in areas such as diet, exercise, and rehabilitation, plus resources to address their psychosocial needs.
Kidney Cancer Survival Rate Data
11/23/2010
The Doctor Con
11/22/2010
One of the tragi-comic sideshows of passing ObamaCare was the Democratic attempt to buy off the American Medical Association . . .
UK: postcode lottery of cancer drugs is already refusing to prescribe life-prolonging treatments
11/22/2010
New Kidney Cancer Drug Met its Primary Endpoint
11/20/2010
Axitinib significantly extended progression-free survival
AVEOs Tivozanib in Combination with FOLFOX6 Demonstrates Anti-tumor Activity
11/19/2010
"These data, in addition to positive tivozanib Phase 2 monotherapy data in patients with advanced kidney cancer, indicate significant potential for tivozanib across multiple tumor types.
Chris Battle: The Return of Death Panels
11/18/2010
If the Centers for Medicare and Medicaid Service and the Food and Drug Administration and god knows what other panels lurking in the lost crevices of our sprawling government decide to block access to Provenge, if they block Avastin, if they block Sutent, who will spend the billions necessary to research, develop, and bring new drugs to market?
Great American Smokeout
11/18/2010
To have the best chance of quitting successfully, you need to know what you're up against, what your options are, and where to go for help.